Navigating the link between patents and regulatory agency approval.
Whether you are an innovative startup biotech company striving to develop your first biological product or one of the largest medical device companies in the world, your fundamental aims are the same: You seek to develop, defend, and fully capitalize on your most valuable assets, likely in the context of an ongoing or future Food and Drug Administration (FDA) clinical trial. A misstep on any of these fronts can hurt you. And that is why businesses of every size, as well as academic and research institutions, regularly turn to Much. We meet all of their global patent counsel and prosecution needs for the full scope and lifecycle of their portfolios. And we can do the same for you.
In just a few short years, clients using our strategies have soared – from mere ideas to multiple biological products undergoing simultaneous FDA clinical trials covered by patent applications worldwide. Our team is also skilled at maneuvering patent portfolios in a way that extends coverage for FDA clinical trial products, which for a life sciences company can be extremely valuable.